Depression and insomnia in cancer: Prevalence, risk factors, and effects on cancer outcomes

Current Psychiatry Reports

Volumn 15, Issue 11, 2013, Pages

  Irwin, Michael R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Cancer; Depression; Depressive symptoms; Fatigue; Inflammation; Insomnia; Major depression; Psychiatry; Sleep disturbance

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE PREDISPOSITION; HUMAN; INSOMNIA; MAJOR DEPRESSION; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; POPULATION RISK; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SLEEP QUALITY; SLEEP TIME; NEOPLASM; PREVALENCE; PSYCHOLOGICAL ASPECT; REVIEW; SURVIVOR; UNITED STATES; DEPRESSIVE DISORDER; PSYCHOLOGY; SLEEP INITIATION AND MAINTENANCE DISORDERS;

DEPRESSIVE DISORDER; HUMANS; NEOPLASMS; PREVALENCE; RISK FACTORS; SLEEP INITIATION AND MAINTENANCE DISORDERS; SURVIVORS; UNITED STATES;

EID: 84893181363     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-013-0404-1     Document Type: Article

References (73)

1. Office of Cancer Survivorship 2009.
2. Raison CL, Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry. 2003;54(3): 283-94. (Pubitemid 37267858)
3. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008;26(6):971-82. (Pubitemid 351409339)
4. Rooney AG, McNamara S, Mackinnon M, Fraser M, Rampling R, Carson A, et al. Frequency, clinical associations, and longitudinal course of major depressive disorder in adults with cerebral glioma. J Clin Oncol. 2011;29(32):4307-12.
5. Patten SB, Williams JV, Lavorato DH, Modgill G, Jette N, Eliasziw M. Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen Hosp Psychiatry. 2008;30(5):407-13.
6. Polsky D, Doshi JA, Marcus S, Oslin D, Rothbard A, Thomas N, et al. Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med. 2005;165(11):1260-6. (Pubitemid 40989590)
7. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57-71.
8. Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, et al. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry. 2008;30(2): 112-26. (Pubitemid 351248974)
9. Walker J, Holm Hansen C, Martin P, Sawhney A, Thekkumpurath P, Beale C, et al. Prevalence of depression in adults with cancer: a systematic review. Ann Oncol. 2013;24(4):895-900.
10. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a metaanalysis of 94 interview-based studies. Lancet Oncol. 2011;12(2): 160-74.
11. Rasic DT, Belik SL, Bolton JM, Chochinov HM, Sareen J. Cancer, mental disorders, suicidal ideation and attempts in a large community sample. Psychooncology. 2008;17(7):660-7.
12. Schag CA, Ganz PA, Polinsky ML, Fred C, Hirji K, Petersen L. Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol. 1993;11(4):783-93. (Pubitemid 23105689)
13. Fann JR, FanMY, Unutzer J. Improving primary care for older adults with cancer and depression. J Gen Intern Med. 2009;24 Suppl 2: S417-24.
14. Honda K, Goodwin RD. Cancer and mental disorders in a national community sample: findings from the national comorbidity survey. Psychother Psychosom. 2004;73(4):235-42. (Pubitemid 38822725)
15. Dalton SO, Laursen TM, Ross L, Mortensen PB, Johansen C. Risk for hospitalization with depression after a cancer diagnosis: a nationwide, population-based study of cancer patients in Denmark from 1973 to 2003. J Clin Oncol. 2009;27(9):1440-5.
16. Ell K, Sanchez K, Vourlekis B, Lee PJ, Dwight-Johnson M, Lagomasino I, et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol. 2005;23(13):3052-60. (Pubitemid 46224127)
17. Himelhoch S, Weller WE, Wu AW, Anderson GF, Cooper LA. Chronic medical illness, depression, and use of acute medical services among Medicare beneficiaries. Med Care. 2004;42(6):512-21.
18. Stein BD, Meili R, Klein D. Datapoints: general medical costs of recipients of behavioral health care. Psych Serv. 2006;57(5):620.
19. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285(11):1466-74. (Pubitemid 32221895)
20. Barefoot JC, Brummett BH, Helms MJ, Mark DB, Siegler IC, Williams RB. Depressive symptoms and survival of patients with coronary artery disease. Psychosom Med. 2000;62(6):790-5. (Pubitemid 32009085)
21. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol. 2008;5(8):466-75.
22. Satin JR, LindenW, PhillipsMJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115(22):5349-61.
23. Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010;40(11):1797-810.
24. Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006;28(5):396-402. (Pubitemid 44572113)
25. Mykletun A, Bjerkeset O, Dewey M, Prince M, Overland S, Stewart R. Anxiety, depression, and cause-specific mortality: the HUNT study. Psychosom Med. 2007;69(4):323-31. (Pubitemid 46800292)
26. Pirl WF, Greer JA, Traeger L, Jackson V, Lennes IT, Gallagher ER, et al. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol. 2012;30:1310-1315.
27. Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, et al. Insomnia as a predictor of depression: a metaanalytic evaluation of longitudinal epidemiological studies. J Affect Dis. 2011;135(1-3):10-9.
28. Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Fitzgerald JD, Ranganath VK, et al. Sleep loss exacerbates fatigue, depression, and pain in rheumatoid arthritis. Sleep. 2012;35(4):537-43.
29. Irwin MR, Cole SW. Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol. 2011;11(9):625-32.
30. Irwin MR, Carrillo C, Olmstead R. Sleep loss activates cellular markers of inflammation: sex differences. Brain Behav Immun. 2010;24(1):54-7.
31. IrwinMR,WangM, Ribeiro D, Cho HJ,Olmstead R, Breen EC, et al. Sleep loss activates cellular inflammatory signaling. Biol Psychiatry. 2008;64(6):538-40.
32. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med. 2006;166(16):1756-62. (Pubitemid 44414465)
33. Irwin MR, Miller AH. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun. 2007;21(4):374-83. (Pubitemid 46528684)
34. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436-44.
35. Sigurdardottir LG, Valdimarsdottir UA, Fall K, Rider JR, Lockley SW, Schernhammer E, et al. Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol Biomark Prev. 2012;21(7):1002-11.
36. Savard J,Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol. 2001;19(3):895-908. (Pubitemid 32119105)
37. Liu L, Ancoli-Israel S. Sleep disturbances in cancer. Psychiat Ann. 2008;38(9):627-34.
38. Fiorentino L, Ancoli-Israel S. Insomnia and its treatment in women with breast cancer. Sleep Med Rev. 2006;10(6):419-29. (Pubitemid 44810065)
39. Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24(5):583-90. (Pubitemid 32660384)
40. Bardwell WA, Profant J, Casden DR, Dimsdale JE, Ancoli-Israel S, Natarajan L, et al. The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology. 2008;17(1):9-18. (Pubitemid 351166272)
41. Davidson JR, MacLean AW, Brundage MD, Schulze K. Sleep disturbance in cancer patients. Soc Sci Med. 2002;54(9):1309-21. (Pubitemid 34240048)
42. Palesh OG, Roscoe JA,Mustian KM, Roth T, Savard J, Ancoli-Israel S, et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol. 2010;28(2):292-8.
43. Savard J, Villa J, Ivers H, Simard S, Morin CM. Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2- month period. J Clin Oncol. 2009;27(31):5233-9.
44. Savard J, Ivers H, Villa J, Caplette-Gingras A, Morin CM. Natural course of insomnia comorbid with cancer: an 18-month longitudinal study. J Clin Oncol. 2011;29(26):3580-6.
45. Miaskowski C, Paul SM, Cooper BA, Lee K, Dodd M,West C, et al. Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy. Sleep. 2011;34(2):171-9.
46. Desai K, Mao JJ, Su I, Demichele A, Li Q, Xie SX, et al. Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors. Support Care Cancer. 2013;21(1):43-51.
47. Savard J, Hervouet S, Ivers H. Prostate cancer treatments and their side effects are associated with increased insomnia. Psychooncology. 2013;22(6):1381-8.
48. Silberfarb PM, Hauri PJ, Oxman TE, Schnurr P. Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol. 1993;11(5):997-1004. (Pubitemid 23146099)
49. Hanisch LJ, Gooneratne NS, Soin K, Gehrman PR, Vaughn DJ, Coyne JC. Sleep and daily functioning during androgen deprivation therapy for prostate cancer. Eur J Cancer Care (Engl). 2011;20(4): 549-54.
50. Liu L, Rissling M, Natarajan L, Fiorentino L, Mills P, Dimsdale J, et al. The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy. Sleep. 2012;35:237-45.
51. Cho HJ, Lavretsky H, Olmstead R, Levin MJ, Oxman MN, Irwin MR. Sleep disturbance and depression recurrence in communitydwelling older adults: a prospective study. Am J Psychiatry. 2008;165(12):1543-50.
52. Clevenger L, SchrepfA,DegeestK, Bender D,GoodheartM,Ahmed A, et al. Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis. Cancer. 2012;26(7):1037-44.
53. Ayas NT,White DP,Manson JE, StampferMJ, Speizer FE,Malhotra A, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003;163(2):205-9. (Pubitemid 36120188)
54. Mallon L, Broman JE, Hetta J. Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. J Intern Med. 2002;251(3):207-16. (Pubitemid 34227184)
55. Althuis MD, Fredman L, Langenberg PW, Magaziner J. The relationship between insomnia and mortality among communitydwelling older women. J Am Geriatr Soc. 1998;46(10):1270-3. (Pubitemid 28467431)
56. Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF, et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc. 2000;48(2):115-23. (Pubitemid 30106514)
57. Dew MA, Hoch CC, Buysse DJ, Monk TH, Begely AE, Houck PR, et al. Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med. 2003;65:63-73. (Pubitemid 36143197)
58. Haus EL, Smolensky MH. Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep Med Rev. 2013;17(4):273-84.
59. Kubo T, Oyama I, Nakamura T, Shirane K, Otsuka H, Kunimoto M, et al. Retrospective cohort study of the risk of obesity among shift workers: findings from the Industry-based Shift Workers' Health study, Japan. Occup Environ Med. 2011;68(5):327-31.
60. Kubo T, Ozasa K, Mikami K,Wakai K, Fujino Y, Watanabe Y, et al. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol. 2006;164(6):549-55. (Pubitemid 44412783)
61. Conlon M, Lightfoot N, Kreiger N. Rotating shift work and risk of prostate cancer. Epidemiol. 2007;18(1):182-3. (Pubitemid 46005923)
62. Parent ME, El-ZeinM, RousseauMC, Pintos J, Siemiatycki J. Night work and the risk of cancer among men. Am J Epidemiol. 2012;176(9):751-9.
63. Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health. 2007;33(5):336-43. (Pubitemid 350186761)
64. Jiao L, Duan Z, Sangi-Haghpeykar H, Hale L, White DL, El-Serag HB. Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer. 2013;108(1):213-21.
65. von Ruesten A, Weikert C, Fietze I, Boeing H. Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLoS One. 2012;7(1):e30972.
66. Irwin MR, Olmstead RE, Ganz PA, Haque R. Sleep disturbance, inflammation and depression risk in cancer survivors. Brain Behav Immun. 2013;30:S58-67.
67. Cole SW. Chronic inflammation and breast cancer recurrence. J Clin Oncol. 2009;27(21):3418-9.
68. Wang XS, Shi Q, Williams LA, Mao L, Cleeland CS, Komaki RR, et al. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun. 2010;24(6):968-74.
69. Mills PJ, Ancoli-Israel S, Parker B, Natarajan L, Hong S, Jain S, et al. Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer. Brain Behav Immun. 2008;22(1):98-104. (Pubitemid 350216367)
70. Mills PJ, Parker B, Jones V, Adler KA, Perez CJ, Johnson S, et al. The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancer. Clin Cancer Res. 2004;10(15):4998-5003. (Pubitemid 39099773)
71. Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, et al. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun. 2012;29:706-713.
72. Liu L, Rissling M, Natarajan L, Fiorentino L, Mills PJ, Dimsdale JE, et al. The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy. Sleep. 2012;35(2): 237-45.
73. Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol. 2011;29(26):3517-22.